Securities code: 002932 securities abbreviation: Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) Announcement No.: 2022-005 Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932)
Announcement on the total reduction of more than 1% and more than half of the shares held by the concerted action of the actual controller
Ms. Chen Lili, Ms. Wang Ying, Xinyu chenheng investment partnership (limited partnership) and Mr. Wang Rui guarantee that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor.
Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) (hereinafter referred to as “the company”) disclosed the pre disclosure announcement on the share reduction plan of the person acting in concert of the actual controller (Announcement No.: 2021-128) on November 23, 2021. The actual controller of the company, Ms. Chen Lili Ms. Wang Ying’s concerted actor, Xinyu chenheng investment partnership (limited partnership) (hereinafter referred to as “Xinyu chenheng”), and Mr. Wang Rui, deputy general manager and Secretary of the board of directors of the company, plan to reduce the total shares of the company by means of centralized bidding and block trading by no more than 2956420 shares (the number to be reduced shall not exceed 2.82% of the total share capital of the company). See China Securities Journal for details Securities times and cninfo（ http://www.cn.info.com.cn. ）。
On February 8, 2022, the company received a notice from Mr. Wang Rui, deputy general manager and Secretary of the board of directors of Xinyu chenheng and learned that Xinyu chenheng and Mr. Wang Rui reduced their shares of the company through centralized bidding and block trading, with a total reduction of more than 1% and more than half of the shares. The details are as follows:
1、 Shareholder reduction
1. Share reduction by shareholders
Average number of shares reduced
Share reduction of shareholders in the total shares of the company
Reduction method: ratio of price (yuan) / share source name (share) and share capital during the reduction period
Shares)
Cases (%)
Before the initial public offering, the shares were issued in January 2022. Wang Rui’s centralized bidding was 91.54 133500 0.13
August 10 and shares granted under equity incentive
Subtotal 133500 0.13
In January 2022, the shares were issued on October 10 before the initial public centralized bidding of 92.31 177000 0.17
Block trading January 2022
July 10 77.21 40000.04
January 2022
September 11 94.87 141100 0.13
Xinyu’s initial public chenheng centralized bidding was 93.62 170180 0.16 on January 12, 2022
Issue of shares January 2022
August 13 101.95 178000 0.17
February 2022
June 7 69.75 186300 0.18
block trade
February 2022
August 8 70.20 1575248 1.50
Subtotal 2467828 2.35
Total 2601328 2.48
1. Basic information
Information disclosure obligor: Chen Lili
Address: No. 48, No. 195-7, Jiefang Avenue, Baofeng sub district office, Qiaokou District, Wuhan City, Hubei Province
Information disclosure obligor Wang Ying
Address: No. 528-1-23-3, Wuluo Road, Wuchang District, Wuhan City, Hubei Province
Information disclosure obligor: Wang Rui
Address: No. 528-1-23-3, Wuluo Road, Wuchang District, Wuhan City, Hubei Province
Information disclosure obligor: Xinyu chenheng investment partnership (limited partnership)
Address: No. 1109, industrial exhibition hall, Xincheng Avenue, high tech Development Zone, Xinyu City, Jiangxi Province
The change time of equity is from December 21, 2021 to the disclosure date of this announcement
Stock abbreviation Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) stock code 002932
Type of change (increase □ decrease \uf0fe concerted action \uf0fe none □
(multiple choice)
Whether it is the largest shareholder or actual controller yes \uf0fe no □
2. Changes in equity this time
Type of shares (A shares) number of shares (shares) reduction proportion (%)
A shares 2601328 2.48
Total 2601328 2.48
The way of this equity change (can be through the centralized trading of the stock exchange \uf0fe
Multiple choice) block trading through the stock exchange \uf0fe
Others □ (please specify)
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change the nature of shares held after this change accounts for the proportion of total share capital to total share capital (%) the proportion of shares (shares) (%)
Chen Lili 28340568 27.02
Wang Ying 16178058 15.43 16178058 15.43
Wang Rui 1601567 1.53 1468067 1.40
Xinyu chenheng investment partnership 2656420 2.53 188592 0.18 (limited partnership)
Total shares held 48776613 46.51 46175285 44.03
Including: shares with unlimited sales conditions 14140343 13.48 11585141 11.05
Shares with limited sales conditions 34636270 33.03 34590144 32.98
4. Implementation of commitments, plans, etc
Yes \uf0fe no □
Xinyu chenheng investment partnership (limited partnership) (hereinafter referred to as “Xinyu chenheng”) and Mr. Wang Rui have pre disclosed the reduction plan in accordance with relevant regulations, For details, please refer to the pre disclosure announcement on the share reduction plan of the actual controller acting in concert (Announcement No.: 2021-128) disclosed by the company on cninfo.com on November 23, 2021.
On December 20, 2021, Mr. Wang Rui reduced 61500 shares of the company through centralized bidding transaction, accounting for about 0.06% of the total share capital of the company. For details, see the suggestive announcement on changes in shareholders’ equity (Announcement No.: 2021-135) and the simplified report on changes in equity disclosed by the company on cninfo.com on December 21, 2021;
Whether this change is to fulfill the commitment, intention and reduction of 133500 shares of the company made by Mr. Wang Rui through centralized bidding on January 10, 2022, accounting for 0.13% of the total share capital of the company;
From January 10, 2022 to January 13, 2022, Xinyu chenheng plans to reduce 666280 shares of the company through centralized bidding transactions, accounting for 0.64% of the total share capital of the company;
From January 10, 2022 to February 8, 2022, Xinyu chenheng reduced 1801548 shares of the company through block trading, accounting for 1.72% of the total share capital of the company;
From the disclosure of the simplified equity change report by the company on December 21, 2021 to February 8, 2022, Xinyu chenheng and Mr. Wang Rui jointly reduced 2601328 shares of the company, accounting for 2.48% of the total share capital of the company.
As of the date of this announcement, the reduction of Xinyu chenheng and Mr. Wang Rui is consistent with the previously disclosed reduction plan and relevant commitments. The amount of reduction is within the scope of the disclosed reduction plan, and the above reduction plan has not been implemented.
Whether the change violates the securities law and the measures for the administration of the acquisition of listed companies yes □ no \uf0fe etc
